Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Shukra Pharmaceuticals Ltd
Your Vote -
Buy
57.14%
Hold
21.43%
Sell
21.43%
57.14%
14 users have voted
Option Chain
Analyzes market sentiment, predicts Shukra Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Shukra Pharma. posts Q4 net loss of Rs 1.73 cr
-
Shukra Pharma. - Announcement under Regulation 30 (LODR)-Allotment
-
Shukra Pharma. - Corporate Action-Board approves Dividend
-
Shukra Pharma. - Regulation 32 For Starement Of Deviation
-
Shukra Pharma. - Results For The Financial Year Ended March 31, 2026
-
Shukra Pharma. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Shukra Pharma. - Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March
-
Shukra Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Shukra Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Shukra Pharma. - Board Meeting Outcome for Independent Directors Meeting
-
Shukra Pharma. - Board Meeting Intimation for Independent Directors Meeting
Key fundamentals
Evaluate the intrinsic value of Shukra Pharmaceuticals Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 94.852 | 67.0125 | 60.7935 | 30.3783 | 19.7265 |
| Liabilities | 94.852 | 67.0125 | 60.7935 | 30.3783 | 19.7265 |
| Equity | 43.7879 | 43.7879 | 10.947 | 3.9142 | 1.5657 |
| Gross Profit | 28.7237 | 12.7297 | 19.4033 | 5.3633 | 2.8857 |
| Net Profit | 22.048 | 9.5751 | 18.5372 | 4.4065 | 0.7507 |
| Cash From Operating Activities | 3.1486 | 7.9184 | -5.1967 | 3.1695 | 7.7843 |
| NPM(%) | 38.88 | 29.38 | 24.85 | 7.48 | 3.66 |
| Revenue | 56.7061 | 32.5873 | 74.5729 | 58.8337 | 20.486 |
| Expenses | 27.9824 | 19.8576 | 55.1696 | 53.4704 | 17.6003 |
| ROE(%) | 24.53 | 10.65 | 20.63 | 4.9 | 0.83 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Shukra Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 715.65 | -1.70 | 0.00 | 15.99 | -26.19 | 0.70 |
| Lotus Eye Hospital and Institute Ltd | 111.00 | 3.69 | 352.97 | 58.27 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 17.34 | -0.29 | 0.00 | 120.99 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 744.50 | -1.50 | 0.00 | 54.95 | -363.15 | 0.00 |
Company Info
1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1. 2025-The Company has splits its face value from Rs. 10/- to Rs. 1/-.-Shukra Pharmaceuticals bags Rs 24.06 cr Government-Backed Supply Contract for Afghanistan
1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1. 2025-The Company has splits its face value from Rs. 10/- to Rs. 1/-.-Shukra Pharmaceuticals bags Rs 24.06 cr Government-Backed Supply Contract for Afghanistan
Read More
Parent Organisation
Shukra Pharmaceuticals Ltd.
Founded
04/03/1993
Managing Director
Mr.Dakshesh Rameshchandra Shah
NSE Symbol
FAQ
The current price of Shukra Pharmaceuticals Ltd is
The 52-week high for Shukra Pharmaceuticals Ltd is
The market capitalization of Shukra Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Shukra Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Shukra Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shukra Pharmaceuticals Ltd shares.
The CEO of Shukra Pharmaceuticals Ltd is Mr.Dakshesh Rameshchandra Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
